Cable Hill Partners LLC Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cable Hill Partners LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 710 shares of the medical equipment provider’s stock after purchasing an additional 51 shares during the quarter. Cable Hill Partners LLC’s holdings in Intuitive Surgical were worth $371,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $28,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new position in shares of Intuitive Surgical during the third quarter worth about $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.3 %

ISRG stock opened at $580.93 on Thursday. The firm has a 50 day moving average of $568.10 and a 200-day moving average of $527.65. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The company has a market cap of $206.92 billion, a price-to-earnings ratio of 90.63, a PEG ratio of 5.85 and a beta of 1.39.

Insider Activity

In related news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 6,240 shares of company stock worth $3,529,040. Company insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ISRG. Royal Bank of Canada raised their price target on Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.